Business
J&J advances potential breakthrough drug as Microsoft pursues acquisitions
Johnson & Johnson moves forward with a drug described as potentially transformative, while Microsoft pursues a series of major buyouts.
Johnson & Johnson moves forward with a drug described as potentially transformative, while Microsoft pursues a series of major buyouts.